Aspen Aerogels (ASPN) Warns of Industry Uncertainty

Aspen Aerogels, Inc. (NYSE: ASPN) has pre-announced its full-year 2023 revenues of $238 million, with $84 million in Q4, and is expecting a potential over 47% year-over-year revenue growth in 2024. The company also initiated supplemental supply for its energy industrial products in Q4 of 2023.

Don Young, Aspen's President and CEO, expressed confidence in the company's future, stating, "The successful launch of our supplemental supply provides critical capacity that we believe will enable our energy industrial business to live up to its full demand potential."

He added, "We are proud of the results that the team delivered in 2023 by effectively doubling our revenues in two years, a goal that we’ve been striving for since early 2021."

Ricardo C. Rodriguez, Chief Financial Officer and Treasurer, commented on the 2024 outlook, saying, "There’s potential for further growth beyond our current 2024 expectations. However, we remain cautious given the challenges that our customers face with launching and scaling new EV nameplates."

He continued, "We believe our best hedge to this uncertainty is continuing to optimize our cost structure, maximize the potential of our energy industrial business, broaden our EV customer base, right-time capital expenditures, and identify further operating efficiencies."

The company's full 8-K submission is available here.

2018 2019 2020 2021 2022 2023
Revenue (k) $104,361 $139,375 $100,273 $121,622 $180,364 $214,110
Revenue Growth n/a 33.55% -28.06% 21.29% 48.3% 18.71%
Operating Margins -32% -10% -22% -33% -44% -28%
Net Margins -33% -10% -22% -30% -46% -26%
Net Income (k) -$34,440 -$14,565 -$21,809 -$37,094 -$82,738 -$54,901
Net Interest Expense (k) -$524 -$406 -$240 -$229 $1,617 $6,596
Depreciation & Amort. (k) $10,787 $10,213 $10,198 $9,440 $9,222 $13,287
Free Cash Flow (k) -$12,247 -$3,166 -$13,340 -$32,406 -$272,373 -$270,208
Capital Expenditures $3,593 $2,112 $3,416 $13,778 $177,974 $206,295
Current Ratio 1.61 1.5 3.38 3.07 4.68 3.27
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS